Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women
about
Interventions for preventing recurrent urinary tract infection during pregnancyProbiotics for preventing urinary tract infections in adults and childrenInterventions for preventing recurrent urinary tract infection during pregnancyInterventions for preventing recurrent urinary tract infection during pregnancyNew approaches to making the microenvironment of the female reproductive tract hostile to HIV.Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants.The role of lactobacilli and probiotics in maintaining vaginal health.Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI.Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infectionProbiotic Properties of Lactobacillus crispatus 2,029: Homeostatic Interaction with Cervicovaginal Epithelial Cells and Antagonistic Activity to Genitourinary Pathogens.Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.Evaluation of profertility effect of probiotic Lactobacillus plantarum 2621 in a murine model.Recurrent urinary tract infections in children: Preventive interventions other than prophylactic antibioticsDrug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosisCytoprotective Effect of Lactobacillus crispatus CTV-05 against Uropathogenic E. coli.
P2860
Q24186322-9F444799-B16E-477B-B28E-631C0B33F03EQ24186954-27249CCC-C705-4C3C-A963-BF84E4016003Q24202838-FB4C716C-423E-4100-9975-B15910D0147DQ24235179-6A236372-3BB9-4E95-A927-5AD42AD62BDCQ30398454-D7D5F331-7444-4B05-8786-32C78281C7AFQ34165056-6CEFEB05-D9D1-4CFD-A006-C8FF5003A54FQ34381043-8C9B5E6F-E23C-4CB1-AA6F-E17DC3D101A9Q34535160-C93CB360-2CC4-426E-8FB8-B52D47B59DA5Q34814831-B1398C64-6981-456E-8BB4-22F3174AB2ECQ35207445-B58936E3-56A9-44EE-B663-6538ED105A07Q35346663-C3383553-D418-405B-8D98-DA42F25FCBF5Q35742149-483DE34B-D3E6-47F3-AAF2-033E5FE42674Q35788472-CD33F19E-C5D2-4BD0-9A67-D67FA0198476Q36951570-EE7EB04D-1C27-4C50-9481-C3CEE1680AAFQ37377950-74F40405-4FC2-4AEB-9161-D020F71F9ED4Q54339663-0F7048D3-2788-4FA0-8A3C-0CCE26D15085
P2860
Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Phase I trial of a Lactobacill ...... inary tract infection in women
@ast
Phase I trial of a Lactobacill ...... inary tract infection in women
@en
type
label
Phase I trial of a Lactobacill ...... inary tract infection in women
@ast
Phase I trial of a Lactobacill ...... inary tract infection in women
@en
prefLabel
Phase I trial of a Lactobacill ...... inary tract infection in women
@ast
Phase I trial of a Lactobacill ...... inary tract infection in women
@en
P2093
P2860
P356
P1476
Phase I trial of a Lactobacill ...... inary tract infection in women
@en
P2093
Christopher A Czaja
Walter E Stamm
Yuliya Yarova-Yarovaya
P2860
P356
10.1155/2007/35387
P577
2007-01-01T00:00:00Z